• Posted by:
• HIL Applied Medical
• No comments

HIL is selected as a Silicon70 2018 Company HIL was selected as one of the 70 featured companies in Silicon70 2018, Silicon Review magazine’s annual issue highlighting leading startups. In the feature, HIL’s CEO, Mr. Sagi Brink-Danan, shared the inspiration …

• Posted by:
• HIL Applied Medical
• No comments

HIL is awarded the Horizon 2020 Seal of Excellence The European Commission managing Horizon 2020 – the EU Framework Programme for Research and Innovation – evaluated HIL’s Phase-II proposal as a high-quality project as part of its highly competitive evaluation process. This means …

• Posted by:
• HIL Applied Medical
• No comments

HIL Co-Founder and CTO, Prof. Arie Zigler, announced as a finalist for Berthold Leibinger Innovationspreis 2018 Prof. Arie Zigler, HIL’s Co-Founder and CTO, was announced as a finalist for the Berthold Leibinger Innovationspreis of 2018. Professor Zigler was chosen as …

• Posted by:
• HIL Applied Medical
• No comments

HIL Featured in The Marker Magazine In its special issue for the 2018 MIXiii Biomed Conference and Exhibition, The Marker Magazine tells the story of HIL and its unique Proton Therapy solution. HIL’s CEO Mr. Sagi Brink-Danan shared our vision and his own …

• Posted by:
• HIL Applied Medical
• No comments

HIL makes the shortlist of the Future Planet Awards 2018 HIL was shortlisted for the second annual Future Planet Awards, a prize given to startups that are going to change the world for the better. Future Planet Awards are given by …

• Posted by:
• HIL Applied Medical
• No comments

HIL awarded two new US patents. These two latest additions – granted to HIL during the past two months – bring HIL’s patent portfolio to over three-dozen granted and pending patents worldwide, out of which over 20 have already been …

• Posted by:
• HIL Applied Medical
• No comments

HIL scientists publish a paper in HPLSE Journal Omer Shavit, Yair Ferber, Evgeny Papeer, Arie Zigler – all R&D Physicists at HIL, – et. al. recently published a paper titled “Femtosecond laser-induced damage threshold in snow micro-structured targets”. The research …

• Posted by:
• HIL Applied Medical
• No comments

Mr. Lior Buchman (CPA) joins HIL’s Board of Directors Mr. Buchman has over 20 years of experience in senior corporate financing, mergers & acquisitions, investor relations, operational and business development. Currently the CFO of Integra Holdings Ltd, he has served as …